Double Blind Randomized Controlled Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength of These Muscles During Locomotion in Chronic Hemiparetic Patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Paresis
- Focus Registrational; Therapeutic Use
- Acronyms FOLOTOX
- 12 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Oct 2017 Planned End Date changed from 1 Sep 2017 to 30 May 2018.
- 12 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 30 May 2018.